sales@scalarmarketresearch.com |  +1-800-213-5170  (U.S./ Canada Toll-free) |  REGISTER |  SIGN IN

Home >> Reports >> synthetic biology market

report

Synthetic Biology Market, by Product (Core Products and Enabling Products), Application (Chemical, Healthcare and Agriculture), Technology (Genome Engineering, DNA Sequencing, Bioinformatics and Biological Components and Integration Systems) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022

HC139 October 2016 96 FREE 10% CUSTOMIZATION

Synthetic Biology Market is worth USD 2.64 billion in 2014 and is expected to reach USD 37.21 billion by 2022, growing at a CAGR of 27.7% from 2014 to 2022.

The global synthetic biology market report offers in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, forecast for the next five years, key market players, and premium industry trends. It also focuses on the key drivers, restraints, opportunities and challenges in the synthetic biology market.

KEY BENEFITS OF THE REPORT

  • Extensive evaluation of all the market dynamics that will impact this market during the forecast period
  • Granular understanding of the historical market trend and the resultant market forecast
  • Deeper understanding of the behavior of the key players and innovators influencing this market

KEY PREMIUM INDUSTRY INSIGHTS

  • The synthetic biology market is witnessing tremendous growth as the demand for the renewal fuels, bio-based chemicals, expensive drugs, and vaccines that utilize synthetic biology are increasing at a rapid rate.
  • The organization such as BioBricks, DIYbio, and SynBERC are participating in developing the synthetic biology products, which is anticipated to increase the demand for the market during the forecast period.
  • Apart from that, the increase in the research and development expenditure in pharmaceutical and biotechnology industries, the rising demand for the synthetic genes, and the increasing production of the genetically modified crops will further boost the demand for the synthetic biology market.
  • A large number of key players such as Novozymes, Amyris, and others are constantly increasing their research and development expenses to develop novel products, leading to the overall growth of the market in the near future.
  • The rising demand for protein therapy will also create the growth opportunities for the global market.
  • However, high expenses, safety, and regulatory changes are the main restraining factors for the market. 
  • Standardization and integration of the biological parts at the system-level remains the major challenge for the development of this market in the developing as well as the developed regions.

RESEARCH METHODOLOGY

The research methodology for Scalar Market Research’s synthetic biology market report utilizes a combination of top-down and bottom-up research formats. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

To know about the assumptions considered for the study Download PDF Sample.

MARKET SEGMENTATION

This report analyzes the synthetic biology market by the following segments:

  • Synthetic Biology Market, by Products
    • Core Products
    • Enabling Products
  • Synthetic Biology Market, by Applications
    • Chemicals
    • Healthcare
    • Agriculture
    • Others
  • Synthetic Biology Market, by Technology
    • Genome Engineering
    • DND Sequencing
    • Bioinformatics
    • Biological components and integrated systems
    • Others

KEY MARKET PLAYERS

Key players in the synthetic biology market include:

  • Amyris
  • DuPont
  • GenScript
  • Intrexon
  • Integrated DNA Technologies, Inc.
  • New England Biolabs
  • Novozymes
  • Koninklijke DSM N.V.
  • Synthetic Genomics Inc.
  • Thermo Fisher Scientific Inc.

GEOGRAPHIC COVERAGE AND ANALYSIS

This granular market research report covers the following geographic regions in great detail:

Synthetic Biology Market

TRENDING RELATED REPORT

Biosimilars Market, by Product Types (Recombinant Glycosylated Proteins, Recombinant Non-Glycosylated Proteins, Recombinant Peptides), Applications (Oncology, Blood Disorders, Infectious Diseases, Autoimmune Diseases, and Others) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022


  1. MARKET OVERVIEW
    • Market Definition
    • Research Methodology
    • Market Segmentation
  2. EXECUTIVE SUMMARY
  3. MARKET DYNAMICS
    • Drivers
    • Restraints
    • Opportunities
    • Premium Industry Trends
  4. INDUSTRY ANALYSIS
    • Approaches for Development of Synthetic Biology Products
    • Risk of Synthetic Biology
    • Regulatory Framework Analysis
  5. SYNTHETIC BIOLOGY MARKET, BY PRODUCTS
    • Segment Share
    • By Products
      • Core Products
      • Enabling Products
  6. SYNTHETIC BIOLOGY MARKET, BY APPLICATIONS
    • Segment Share
    • By Applications
      • Chemicals
      • Healthcare
      • Agriculture
      • Others
  7. SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY
    • Segment Share
    • By Technology
      • Genome Engineering
      • DND Sequencing
      • Bioinformatics
      • Biological components and integrated systems
      • Others
  8. SYNTHETIC BIOLOGY MARKET, BY GEOGRAPHY
    • North America
      • By Country
        • U.S.
        • Rest of North America
      • By Products
      • By Application
      • By Technology
    • Europe
      • By Country
        • France
        • Germany
        • U.K.
        • Rest of Europe
      • By Products
      • By Application
      • By Technology
    • Asia-Pacific
      • By Country
        • China
        • India
        • Japan
        • Rest of Asia-Pacific
      • By Products
      • By Application
      • By Technology
    • Rest of the World
      • By Country
        • Latin America
        • Middle East & Africa
      • By Products
      • By Application
      • By Technology
  9. COMPETITIVE LANDSCAPE
    • Key Innovators
  10. KEY MARKET PLAYERS
    • Amyris
      • Overview
      • Key Strategies
      • Recent Developments
    • DuPont
      • Overview
      • Key Strategies
      • Recent Developments
    • GenScript
      • Overview
      • Key Strategies
      • Recent Developments
    • Intrexon
      • Overview
      • Key Strategies
      • Recent Developments
    • Integrated DNA Technologies, Inc.
      • Overview
      • Key Strategies
      • Recent Developments
    • New England Biolabs
      • Overview
      • Key Strategies
      • Recent Developments
    • Novozymes
      • Overview
      • Key Strategies
      • Recent Developments
    • Koninklijke DSM N.V.
      • Overview
      • Key Strategies
      • Recent Developments
    • Synthetic Genomics Inc.
      • Overview
      • Key Strategies
      • Recent Developments
    • Thermo Fisher Scientific Inc.
      • Overview
      • Key Strategies
      • Recent Developments
  11. SCALAR 360 DEGREE MARKET PERSPECTIVE
  12. APPENDIX
Please submit your enquiry below so our representative can get in touch with you
*
*
*
*
*
*

USA - CANADA TOLL FREE
+1-800-213-5170

EMAIL
sales@scalarmarketresearch.com

Benefits of Buying From Scalar

Unparalleled Expertise

Our industry experts hold inimitable know-how across wide range of industry verticals

Assured Quality

We deliver high-quality, real-time and data-driven industry insights to our clients

24x7 Analyst Support

We offer pre-purchase and post-purchase support from our industry experts

Privacy & Security

All your personal information and confidential details are safe and secure with us